tiprankstipranks
Trending News
More News >
Magnera (MAGN)
NYSE:MAGN

Magnera (MAGN) AI Stock Analysis

Compare
157 Followers

Top Page

MAGN

Magnera

(NYSE:MAGN)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
$11.00
▼(-0.63% Downside)
Action:ReiteratedDate:03/13/26
The score is held back primarily by weak financial quality (recurring net losses, compressed margins, and elevated leverage) and bearish technicals (price below key moving averages with negative MACD). Offsetting factors include improving, positive cash generation and a more constructive outlook from reaffirmed FY2026 adjusted EBITDA growth guidance and planned debt reduction, while valuation is difficult to assess given negative earnings and no dividend yield data.
Positive Factors
Revenue scale & growth
A multi-year revenue increase to $3.2B provides durable scale benefits: better fixed-cost absorption, stronger commercial reach and diversification across end markets. This larger top line makes operational improvement and margin recovery more achievable over the medium term, supporting sustainable EBITDA expansion.
Positive cash generation and liquidity
Consistent positive operating cash flow and sizable available liquidity give Magnera durable financial flexibility to fund integration, invest in higher‑margin innovation and execute debt paydowns. Positive FCF despite net losses lowers refinancing risk and supports prioritized deleveraging and capital allocation plans.
Clear deleveraging plan & synergy program
A concrete plan combining targeted synergies (Project CORE), product innovation and explicit debt repayment creates a structural path to improved credit metrics. If executed, these initiatives should sustainably reduce interest burden and increase free cash flow available for reinvestment and further deleveraging.
Negative Factors
Persistent net losses & margin compression
Repeated bottom‑line losses and a structurally compressed gross margin constrain equity accumulation and make earnings recovery more challenging. Persistent negative net income limits internal capital for R&D and capex, increasing reliance on cost actions and external financing to restore sustainable profitability.
Elevated leverage and modest coverage
High absolute debt relative to equity and modest operating cash flow raise refinancing and interest coverage risks, limiting strategic flexibility. Even with planned repayments, elevated leverage increases vulnerability to cyclical demand shocks and slows ability to invest in growth without further deleveraging.
Regional structural headwinds & regulatory risk
Sustained market softness in Europe and import-driven weakness in South America create structural revenue and margin pressure in key regions. Competitive import dynamics and potential antidumping actions add regulatory uncertainty that can depress volumes, force pricing/margin concessions and complicate medium‑term recovery.

Magnera (MAGN) vs. SPDR S&P 500 ETF (SPY)

Magnera Business Overview & Revenue Model

Company DescriptionMagnera Corp. engages in a wide range of products, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage industry. The company was founded on November 4, 2024 and is headquartered in Charlotte, NC.
How the Company Makes Moneynull

Magnera Earnings Call Summary

Earnings Call Date:Feb 04, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Positive
The call presented a mix of operational challenges (regional softness in Europe, competitive import pressure in South America, a small Americas EBITDA decline, and weather-related disruptions) but emphasized several positive fundamentals: solid liquidity and cash generation, active debt reduction, on-track Project CORE and synergy realization, targeted innovation launches (PFAS-free healthcare protection, battery materials, Kamisoft), and reaffirmed guidance for ~9% adjusted EBITDA growth in 2026. Management expressed confidence in margin expansion, portfolio optimization, and disciplined capital allocation while acknowledging near-term headwinds.
Q1-2026 Updates
Positive Updates
Quarterly Sales
Net sales of $792 million in Q1 FY2026, driven by strength across consumer solutions despite regional headwinds.
Adjusted EBITDA and Guidance
Adjusted EBITDA of $93 million for the quarter (flat year-over-year on a constant currency basis). Management reaffirmed full-year 2026 adjusted EBITDA guidance targeting ~9% growth.
Rest of World Earnings Improvement
Rest of World adjusted EBITDA increased 9% year-over-year to $35 million, reflecting disciplined cost management and synergy realization despite revenue declines in Europe.
Americas Volume Growth
Americas delivered 2% organic volume growth in the quarter, led by wipes and adult end markets (wipes benefited from elevated flu season demand).
Project CORE and Synergy Progress
Project CORE transformation tracking as planned; expected benefit in the range of $15–$20 million from CORE initiatives. Management expects $25 million of synergy realization in 2026 toward a $55 million total synergy target.
Strong Cash Generation and Liquidity
Free cash flow of $97 million over the last four quarters (approximate free cash flow yield ~18% based on market cap). Available liquidity of about $550 million at quarter-end.
Debt Reduction and Capital Allocation
Repaid $27 million of debt in the quarter and expects to repay approximately $100 million over the fiscal year; disciplined capital allocation and deleveraging target of ~3x leverage ratio.
Notable Product and Technology Innovations
Launched PFAS-free barrier protection for healthcare applications, advanced battery materials candidate for government grant, and expanded Kamisoft (softness platform) with $15 million sales last year and mid-single-digit growth into 2026; innovation margins expected above the corporate average (~11%), often mid-teens to 20%+.
Portfolio and Commercial Wins
Strong performance in premium private-label baby and disinfectant wipes, gains from branded Geca Tape in energy and cable applications, and infrastructure-driven growth in Europe from utility and data-cable spending.
Negative Updates
Top-Line Pressure in Europe
Ongoing broad-based market softness in Europe reduced revenues in the quarter (management noted Europe remains challenging and guided to modest declines for the region).
South America Volume and Competitive Pressure
Year-over-year volume decline in South America due to heightened competitive import pressure from Asia; baby business in South America experienced notable challenges. Management cited antidumping inquiries/potential countermeasures in play, introducing regulatory uncertainty.
Americas Adjusted EBITDA Decline
Adjusted EBITDA in the Americas declined by $3 million year-over-year, largely attributable to volume and product mix pressures in South America despite organic volume growth in North America.
Reported Revenue Impact from Raw Material Pass-Through
Contractual pass-through of lower raw material costs lowered reported revenues in multiple regions (Americas and Rest of World), which reduced top-line but had limited profit impact.
Weather-Related Operational Disruption
Winter storms impacted North American operations and customers, estimated to affect roughly 10% of shipping days in North America and create short-term shipment timing and logistics disruptions.
Q1 Earnings Momentum Was Only Flat
Despite several positives, Q1 adjusted EBITDA was flat year-over-year on a constant currency basis (0% change), indicating near-term pressures that management must convert to the announced ~9% full-year improvement.
Company Guidance
Management reiterated FY2026 targets of adjusted EBITDA growth of 9% while assuming flattish volumes overall (Q1 sales were $792M and adj. EBITDA $93M), calling out Americas organic volume growth of 2% in Q1 and Europe guide of about -3%; key drivers include $25M of synergy realization in 2026 (part of a $55M ultimate synergy target) plus Project CORE benefits of $15–20M, with Rest of World adj. EBITDA up 9% to $35M; liquidity and cash priorities include ~$550M of available liquidity, free cash flow of $97M over the last four quarters (FCF midpoint for FY26 roughly $100M, ~18% yield), a plan to repay about $100M of debt in the year (already repaid $27M), a targeted 3.0x leverage ratio, and planned FY26 assumptions of ~$395M midpoint EBITDA working through ~$135M interest, ~$80M integration/taxes and ~$80M CapEx.

Magnera Financial Statement Overview

Summary
Revenue growth has been strong, but profitability is weak with net losses in four of the last five years and margin compression (2025 net margin ~-5%, gross margin ~9%). Leverage remains elevated (2025 debt-to-equity ~1.9), increasing financial risk. Cash flow has improved with positive operating cash flow (~$103M) and free cash flow (~$36M) in 2025, but coverage versus debt is modest and FCF fell from 2024.
Income Statement
34
Negative
Revenue scaled sharply from $0.92B (2020) to $3.20B (2025), including a strong step-up in 2024, but profitability has deteriorated. Net income is negative in four of the last five annual periods (2022–2025), with 2025 net margin at roughly -5% and gross margin down to ~9% versus ~16% in 2020. EBITDA margin remains positive in 2025 (~6%), suggesting the core business generates operating earnings before non-cash/other items, but the persistent bottom-line losses and margin compression weigh heavily on quality of earnings.
Balance Sheet
38
Negative
Leverage is elevated: 2025 total debt is ~$2.02B against equity of ~$1.06B (debt-to-equity ~1.9), and return on equity is negative due to losses. The balance sheet improved versus the very high leverage profile seen in 2022–2023, but it is weaker than 2024 (when equity was higher and leverage was lower). Overall, the company has meaningful financial risk and limited profitability-driven equity build at present.
Cash Flow
45
Neutral
Cash generation is positive in the most recent two years: 2025 operating cash flow is ~$103M and free cash flow is ~$36M (down from ~$120M in 2024). Earlier periods (2022–2023) showed negative operating and free cash flow, indicating a less stable cash profile through the cycle. A key positive is that free cash flow is positive despite reported net losses in 2024–2025, but coverage is modest (2025 operating cash flow is relatively small versus debt), limiting flexibility.
BreakdownSep 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.20B2.19B1.39B1.49B1.08B
Gross Profit287.00M237.00M129.71M148.80M144.79M
EBITDA190.00M236.00M56.89M-104.46M87.45M
Net Income-159.00M-154.00M-79.05M-194.21M6.94M
Balance Sheet
Total Assets3.99B2.81B1.56B1.65B1.88B
Cash, Cash Equivalents and Short-Term Investments305.00M230.00M50.27M110.66M138.44M
Total Debt2.02B2.06B865.38M849.60M787.36M
Total Liabilities2.92B668.00M1.31B1.33B1.34B
Stockholders Equity1.06B2.14B256.85M318.00M542.76M
Cash Flow
Free Cash Flow36.00M120.00M-59.39M-78.56M40.94M
Operating Cash Flow103.00M192.00M-25.62M-40.82M70.98M
Investing Cash Flow-8.00M-39.00M-37.10M-33.10M-489.77M
Financing Cash Flow-21.00M-109.00M-949.00K46.92M462.35M

Magnera Technical Analysis

Technical Analysis Sentiment
Negative
Last Price11.07
Price Trends
50DMA
13.67
Negative
100DMA
12.66
Negative
200DMA
12.47
Negative
Market Momentum
MACD
-0.69
Positive
RSI
25.73
Positive
STOCH
17.35
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MAGN, the sentiment is Negative. The current price of 11.07 is below the 20-day moving average (MA) of 12.75, below the 50-day MA of 13.67, and below the 200-day MA of 12.47, indicating a bearish trend. The MACD of -0.69 indicates Positive momentum. The RSI at 25.73 is Positive, neither overbought nor oversold. The STOCH value of 17.35 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MAGN.

Magnera Risk Analysis

Magnera disclosed 17 risk factors in its most recent earnings report. Magnera reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Magnera Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$419.71M40.4629.57%19.32%-78.78%-81.27%
65
Neutral
$654.79M32.26-33.37%8.88%-349.99%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
$249.42M17.686.59%-4.24%-23.16%
46
Neutral
$397.41M-3.94-12.41%
44
Neutral
$367.81M13.38
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MAGN
Magnera
11.07
-7.55
-40.55%
HDSN
Hudson Tech
5.80
-0.15
-2.52%
IPI
Intrepid Potash
48.84
22.72
86.98%
MSB
Mesabi Shs
31.99
7.37
29.92%
LZM
Lifezone Metals
4.39
-0.09
-2.01%

Magnera Corporate Events

Executive/Board ChangesShareholder Meetings
Magnera Shareholders Back Board, Auditor and Pay Practices
Positive
Mar 12, 2026

At its 2026 Annual Meeting of Shareholders, held following the January 14, 2026 proxy filing, Magnera’s shareholders elected nine directors to serve until the 2027 annual meeting, with all nominees receiving sufficient support despite one director drawing notably higher opposition. Shareholders also ratified Ernst & Young LLP as the independent auditor for the fiscal year ending September 26, 2026, and approved on an advisory basis the company’s fiscal year 2025 executive compensation program, signaling overall investor support for the firm’s governance, oversight, and pay practices.

These voting outcomes indicate continuity in Magnera’s board leadership and external audit relationship, reducing near‑term uncertainty around corporate oversight. The strong backing for the Say‑on‑Pay proposal suggests that most shareholders are comfortable with how management is being incentivized, which may reinforce the company’s current strategic direction and executive compensation structure.

The most recent analyst rating on (MAGN) stock is a Hold with a $11.50 price target. To see the full list of analyst forecasts on Magnera stock, see the MAGN Stock Forecast page.

Executive/Board Changes
Magnera Appoints Erin Maile as Chief Accounting Officer
Positive
Feb 3, 2026

On January 29, 2026, Magnera Corporation’s board appointed Erin Maile, 34, as Executive Vice President and Chief Accounting Officer effective February 2, 2026, elevating her from her prior role as Vice President, Finance, Corporate Controller, which she has held since November 4, 2024, following earlier senior accounting and reporting roles at Berry Global. The company detailed a compensation package designed to align Maile with shareholder interests, including a $275,000 base salary, eligibility for annual short-term and long-term incentive awards, share ownership requirements, and participation in an executive severance plan with double-trigger change-in-control protections and equity vesting, underscoring Magnera’s emphasis on competitive, governance-conscious executive pay structures with clear protections in the event of leadership changes or corporate transactions.

The most recent analyst rating on (MAGN) stock is a Hold with a $13.50 price target. To see the full list of analyst forecasts on Magnera stock, see the MAGN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 13, 2026